Rocky Mountain Chocolate Factory Reports Fiscal Second Quarter 2025 Financial Results

DURANGO, Colo., Oct. 15, 2024 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), an international franchisor and producer of premium chocolates and other confectionery products including gourmet caramel apples, is reporting financial and operating results for its fiscal second quarter ended August 31, 2024. “We are pleased with […]

Runway Growth Finance Corp. Announces Date for Third Quarter 2024 Financial Results and Conference Call

MENLO PARK, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its third quarter 2024 financial results after market close on Tuesday, November 12, 2024.

Zillow Group to Announce Third-Quarter 2024 Results Nov. 6

Conference call to be webcast live at 2 p.m. PT / 5 p.m. ET Zillow Group, Inc. (Nasdaq: Z and ZG) today announced it will release third-quarter 2024 financial results after market close on Wednesday, Nov. 6, 2024. The company will host a webcast and conference call to discuss its results that afternoon at 2

Endo to Host Investor Call on Third-Quarter 2024 Financial Results

Endo, Inc. (OTCQX: NDOI) (“Endo” or the “Company”) announced today that it will release its third-quarter 2024 financial results on November 5, 2024, prior to market open. Members of Endo’s senior management team will host a conference call and live webcast for investors at 8:30 a.m. ET. https://mma.prnewswire.com/media/530208/Endo_International_plc_Logo.jpg To participate in the call, please dial

IAS to Announce Third Quarter 2024 Financial Results on November 12, 2024

Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced that it will report its third quarter 2024 financial results after the market close on Tuesday, November 12, 2024. Management will host a conference call and webcast to discuss the company’s financial results that day at 5:00 p.m. ET. https://mma.prnewswire.com/media/1136891/Integral_Ad_Science_Logo_v1.jpg

TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter 2024 after market close on Monday, October 28, 2024. The TransMedics management team will host a corresponding conference

10x Genomics Delivers ‘Single Cell for a Single Cent’ with New Chromium Launches

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to democratize access to single cell analysis. The new offerings – GEM-X Flex and GEM-X Universal Multiplex – introduce significant improvements in performance, workflow and cost effectiveness, enabling more researchers to pursue

Allison Transmission Schedules Third Quarter 2024 Earnings Conference Call

Allison Transmission Holdings Inc. (NYSE: ALSN),a leading designer and manufacturer of conventional and electrified vehicle propulsion solutions and the largest global manufacturer of medium- and heavy-duty fully automatic transmissions for commercial and defense vehicles,today announced that it will hold its third quarter 2024 financial results conference call at 5:00 p.m. EDT on Tuesday, October 29,

The Andersons, Inc. to Release Third Quarter Results on November 4

The Andersons, Inc. (Nasdaq: ANDE) will release its financial results for the third quarter 2024 after 4 p.m. Eastern Time on Monday, November 4, 2024. The company will host a webcast on Tuesday, November 5, 2024, at 11 a.m. Eastern Time to discuss the results and provide a company update. https://mma.prnewswire.com/media/74436/THE_ANDERSONS_LOGO.jpg To listen over the

Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq

PARSIPPANY, NJ, Oct. 15, 2024 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that its Series B Preferred Stock investors, Ampersand Capital Partners and 1315 Capital (the “Investors”), have exchanged (the “Exchange”) their existing Series B Preferred Stock for a new issuance of Series C Preferred Stock in order

Scroll to Top